Dashboard
Manage Tickers

BMY BRISTOL MYERS SQUIBB CO

NYSE bms.com


$ 43.73 $ 0.00 (0 %)    

Monday, 27-Oct-2025 09:27:07 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 624.77 $ 0.00 (0 %)
DIA $ 474.87 $ 0.00 (0 %)
SPY $ 682.92 $ 0.00 (0 %)
TLT $ 91.30 $ 0.00 (0 %)
GLD $ 371.14 $ 0.00 (0 %)
$ 43.83
$ 43.93
$ 43.71 x 16
$ 44.00 x 1
-- - --
$ 42.38 - $ 61.00
10,105,883
na
89.21B
$ 0.29
$ 17.67
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 04-24-2025 03-31-2025 10-Q
3 02-12-2025 12-31-2024 10-K
4 10-31-2024 09-30-2024 10-Q
5 07-26-2024 06-30-2024 10-Q
6 04-25-2024 03-31-2024 10-Q
7 02-13-2024 12-31-2023 10-K
8 10-26-2023 09-30-2023 10-Q
9 07-27-2023 06-30-2023 10-Q
10 04-27-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-K
12 10-26-2022 09-30-2022 10-Q
13 07-27-2022 06-30-2022 10-Q
14 04-29-2022 03-31-2022 10-Q
15 02-09-2022 12-31-2021 10-K
16 10-27-2021 09-30-2021 10-Q
17 07-28-2021 06-30-2021 10-Q
18 04-29-2021 03-31-2021 10-Q
19 02-10-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-24-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 07-25-2019 06-30-2019 10-Q
26 04-25-2019 03-31-2019 10-Q
27 02-25-2019 12-31-2018 10-K
28 10-25-2018 09-30-2018 10-Q
29 07-26-2018 06-30-2018 10-Q
30 04-26-2018 03-31-2018 10-Q
31 02-13-2018 12-31-2017 10-K
32 10-26-2017 09-30-2017 10-Q
33 07-27-2017 06-30-2017 10-Q
34 04-27-2017 03-31-2017 10-Q
35 02-21-2017 12-31-2016 10-K
36 10-27-2016 09-30-2016 10-Q
37 07-28-2016 06-30-2016 10-Q
38 04-28-2016 03-31-2016 10-Q
39 02-12-2016 12-31-2015 10-K
40 10-27-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bristol-myers-squibbs-sotyktu-shows-sustained-efficacy-and-safety-at-week-52-in-poetyk-psa-1-trial
Bristol Myers Squibb's Sotyktu Shows Susta...
10/27/2025 11:01:30

New data from the pivotal Phase 3 POETYK PsA-1 trial demonstrated that Sotyktu improved and maintained meaningful clinical resp...

avidity-shareholders-win-big-as-novartis-moves-fast-on-12-billion-deal
Avidity Shareholders Win Big As Novartis M...
10/27/2025 10:11:40

Avidity Biosciences (NASDAQ: RNA) shares soar as Novartis (NYSE: NVS) agrees to acquire them for $12 billion in cash.

Core News & Articles
Evotec Reports $25M Payment From Bristol M...
10/27/2025 07:06:31

Advances made in preclinical pipeline addressing neurodegenerative diseasesEvotec receives US$ 25 m payment to support continue...

reported-saturday-bristol-myers-squibb-presents-phase-1-breakfree-1-data-showing-cd19-nex-t-car-t-therapy-achieves-94-off-immunosuppressive-therapy-in-autoimmune-diseases
Reported Saturday, Bristol Myers Squibb Pr...
10/27/2025 06:55:50

Positive, early results from 71 patients treated across three disease cohorts – systemic sclerosis, systemic lupus erythematosu...

bristol-myers-squibb-systimmune-present-oral-safety-efficacy-results-from-global-phase-1-us-lung-101-trial-of-iza-bren-to-treat-advanced-solid-tumors-data-revealed-promising-antitumor-activity-across-different-tumor-types-manageable-safety-profile
Bristol Myers Squibb, SystImmune Present O...
10/17/2025 14:06:22

REDMOND, Wash. and PRINCETON, N.J., Oct. 17, 2025 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology ...

wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts Spotl...
10/15/2025 11:15:13

bristol-myers-squibb-and-insitro--announced-the-next-phase-of-their-collaboration-to-discover-new-molecules-with-potential-as-new-treatments-for-amyotrophic-lateral-sclerosis-collaboration-extension-builds-on-5-year-agreement-announced-in-2020
Bristol Myers Squibb And insitro Announce...
10/14/2025 20:03:39

insitro, a pioneer in machine learning–driven drug discovery and development, and Bristol Myers Squibb (NYSE:BMY), today announ...

bristol-myers-squibb-to-present-data-from-over-50-oncology-studies-at-esmo-congress-2025-covering-over-10-cancer-types-across-pipeline-and-portfolio
Bristol Myers Squibb To Present Data From ...
10/13/2025 11:01:32

Bristol Myers Squibb (NYSE:BMY) today announced the presentation of data across its oncology portfolio and pipeline at the Euro...

systimmune-announced-first-patient-dosed-in-ph23-izabright-breast01-trial-of-iza-bren-in-previously-untreated-triple-negative-breast-cancer-250m-milestone-payment-triggered-from-bristol-myers-squibb
SystImmune Announced First Patient Dosed I...
10/13/2025 09:09:42

SystImmune, Inc., a clinical-stage biotechnology company, today announced the treatment of the first patient in the IZABRIGHT-B...

bristol-myers-expands-cell-therapy-portfolio-with-orbital-therapeutics-acquisition
Bristol Myers Expands Cell Therapy Portfol...
10/10/2025 14:32:43

Bristol Myers Squibb is acquiring Orbital Therapeutics for $1.5 billion, expanding its RNA and in vivo CAR T-cell therapy portf...

bristol-myers-squibb-agreed-to-acquire-orbital-therapeutics-a-privately-held-biotechnology-for-15b
Bristol Myers Squibb Agreed To Acquire Orb...
10/10/2025 11:02:15

Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with po...

bristol-myers-squibb-launches-cobenfy-connections-with-tv-host-gail-simmons-on-world-mental-health-day-to-combat-schizophrenia-stigma
Bristol Myers Squibb Launches "COBENFY Con...
10/10/2025 10:51:30

price-over-earnings-overview-bristol-myers-squibb
Price Over Earnings Overview: Bristol-Myer...
10/02/2025 21:00:46

these-3-pharma-stocks-are-rallying--and-still-trade-absurdly-cheap
These 3 Pharma Stocks Are Rallying – And S...
10/02/2025 19:43:25

Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount.

health-care-stocks-rally-nike-beats-the-street-whats-moving-markets-wednesday
Health Care Stocks Rally, Nike Beats The S...
10/01/2025 16:56:36

Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps m...

wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-4-dividend-yields
Wall Street's Most Accurate Analysts Weigh...
10/01/2025 11:58:32

bristol-myers-squibbs-anti-mtbr-tau-targeting-antibody-bms-986446-granted-fda-gast-track-designation
Bristol Myers Squibb's Anti-MTBR-Tau-Targe...
10/01/2025 11:06:02

trumps-100-drug-tariffs-a-meaningful-commercial-hit-for-americans-but-loopholes-could-blunt-impact-says-analyst
Trump's 100% Drug Tariffs 'A Meaningful Co...
09/26/2025 13:25:27

President Donald Trump‘s proposed 100% tariffs on pharmaceuticals could have a smaller impact than initially expected, thanks t...

trumps-100-pharmaceutical-tariff-the-270-billion-manufacturing-war-that-could-reshape-your-medicine-cabinet
Trump's 100% Pharmaceutical Tariff: The $2...
09/26/2025 12:01:51

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creatin...

bristol-myers-to-sell-its-pill-for-psoriasis-directly-to-cash-paying-patients--at-80-discount-to-the-drugs-list-price-following-president-donald-trumps-demand
Bristol Myers To Sell Its Pill For Psorias...
09/25/2025 10:57:49

https://www.bloomberg.com/news/articles/2025-09-25/bristol-to-sell-psoriasis-pill-for-80-off-after-trump-demand

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION